Dr. Lao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
B1 floor Cancer Recp C
Ann Arbor, MI 48109Phone+1 734-647-8906
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 2001 - 2004
University of Alabama Medical CenterResidency, Internal Medicine, 1998 - 2001
Icahn School of Medicine at Mount SinaiClass of 1998
Certifications & Licensure
MI State Medical License 2001 - 2026
AL State Medical License 1999 - 2001
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Dinaciclib in Treating Patients With Stage IV Melanoma Start of enrollment: 2009 Jul 01
- PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy Start of enrollment: 2011 Aug 01
- HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Three-Year Overall Survival With Nivolumab Plus Relatlimab in Advanced Melanoma From RELATIVITY-047.Hussein A Tawbi, F Stephen Hodi, Evan J Lipson, Dirk Schadendorf, Paolo A Ascierto
Journal of Clinical Oncology. 2024-12-13 - 2 citationsFirst-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Tri...Georgina V Long, Evan J Lipson, F Stephen Hodi, Paolo A Ascierto, James Larkin
Journal of Clinical Oncology. 2024-11-20 - Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma.Georgina V Long, James Larkin, Dirk Schadendorf, Jean-Jacques Grob, Christopher D Lao
Journal of Clinical Oncology. 2024-11-06
Journal Articles
- Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the BrainKim Margolin, Omid Hamid, Christopher D Lao, Anna C Pavlick, Michael A Postow, F Stephen Hodi, Nikhil I Khushalani, Marc S Ernstoff, Hussein A Tawbi, Igor Puzanov, Ahm..., The New England Journal of Medicine
Grant Support
- Development Of A Melanoma Chemoprevention ModelNational Cancer Institute2006–2010
- Phase I Single-Dose Safety And Pharmacokinetics Clinical Study Of ResveratrolNational Center For Research Resources2005–2006
- Feasibility Of Barrett?S Esophagus Chemoprev Through Eval Of Esophageal ResectNational Center For Research Resources2005
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
